Circulating miRNAs as Potential Biomarkers for Celiac Disease Development

Background & Aims Celiac disease (CeD), an immune-mediated disease with enteropathy triggered by gluten, affects ~1% of the general European population. Currently, there are no biomarkers to predict CeD development. MicroRNAs (miRNAs) are short RNAs involved in post-transcriptional gene regulation, and certain disease- and stage-specific miRNA profiles have been found previously. We aimed to investigate whether circulating miRNAs can predict the development of CeD. Methods Using next-generation miRNA-sequencing, we determined miRNAs in >200 serum samples from 53 participants of the PreventCD study, of whom 33 developed CeD during follow-up. Following study inclusion at 3 months of age, samples were drawn at predefined ages, diagnosis (first anti-transglutaminase antibody (TGA) positivity or diagnostic biopsy) and after the start of a gluten-free diet (GFD). This allowed identification of circulating miRNAs that are deregulated before TGA positivity. For validation of the biomarkers for CeD and GFD response, two additional cohorts were included in subsequent meta-analyses. Additionally, miRNAs were measured in duodenal biopsies in a case-control cohort. Results 53 circulating miRNAs were increased (27) or decreased (26) in CeD versus controls. We assessed specific trends in these individual miRNAs in the PreventCD cohort by grouping the pre-diagnostic samples of the CeD patients (all had negative TGA) by how close to seroconversion (first sample positive TGA) the samples were taken. 8/53 miRNAs differed significantly between controls and samples taken <1 year before TGA positivity: miR-21-3p, miR-374a-5p, 144-3p, miR-500a-3p, miR-486-3p let-7d-3p, let-7e-5p and miR-3605-3p. 6/26 downregulated miRNAs reconstituted upon GFD, including miR-150-5p/-3p, whereas no upregulated miRNAs were downregulated upon GFD. 15/53 biomarker candidates also differed between CeD biopsies and controls, with a concordant direction, indicating that these circulating miRNAs might originate from the intestine. Conclusions We identified 53 circulating miRNAs that are potential early biomarkers for CeD, of which several can be detected more than a year before TGA positivity and some start to normalize upon GFD.

[1]  M. Mearin,et al.  Coeliac disease. , 2022, Nature reviews. Disease primers.

[2]  M. Cybulski,et al.  Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients , 2020, BioMed research international.

[3]  C. Wijmenga,et al.  Systematic Prioritization of Candidate Genes in Disease Loci Identifies TRAFD1 as a Master Regulator of IFNγ Signaling in Celiac Disease , 2020, bioRxiv.

[4]  B. Cukrowska,et al.  Transcriptional and Ultrastructural Analyses Suggest Novel Insights into Epithelial Barrier Impairment in Celiac Disease , 2020, Cells.

[5]  V. Vaira,et al.  A miRNA-Based Blood and Mucosal Approach for Detecting and Monitoring Celiac Disease , 2019, Digestive Diseases and Sciences.

[6]  R. Unger,et al.  Defining the Celiac Disease Transcriptome using Clinical Pathology Specimens Reveals Biologic Pathways and Supports Diagnosis , 2019, Scientific Reports.

[7]  L. Greco,et al.  A Phospholipid Profile at 4 Months Predicts the Onset of Celiac Disease in at-Risk Infants , 2019, Scientific Reports.

[8]  N. Cerf-Bensussan.  Faculty Opinions recommendation of Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[9]  K. Amr,et al.  Circulating microRNAs as potential non-invasive biomarkers in pediatric patients with celiac disease. , 2019, European annals of allergy and clinical immunology.

[10]  C. Wijmenga,et al.  Celiac disease-on-chip: Modeling a multifactorial disease in vitro , 2019, United European gastroenterology journal.

[11]  A. Humphries,et al.  Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology , 2019, Gut.

[12]  C. Wijmenga,et al.  Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease , 2019, Cell.

[13]  Ana Kozomara,et al.  miRBase: from microRNA sequences to function , 2018, Nucleic Acids Res..

[14]  J. Ilonen,et al.  Persistent Alterations in Plasma Lipid Profiles Before Introduction of Gluten in the Diet Associated With Progression to Celiac Disease , 2019, Clinical and translational gastroenterology.

[15]  I. MacRae,et al.  Regulation of microRNA function in animals , 2018, Nature Reviews Molecular Cell Biology.

[16]  P. H. Green,et al.  Global Prevalence of Celiac Disease: Systematic Review and Meta‐analysis , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  T. Patel,et al.  Large Differences in Small RNA Composition Between Human Biofluids , 2018, bioRxiv.

[18]  K. Kaukinen,et al.  Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: A prospective nationwide study , 2018, United European gastroenterology journal.

[19]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[20]  Andreas Vécsei,et al.  Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice. , 2017, Gastroenterology.

[21]  L. Greco,et al.  Presymptomatic Diagnosis of Celiac Disease in Predisposed Children: The Role of Gene Expression Profile. , 2017, Journal of pediatric gastroenterology and nutrition.

[22]  Andreas Keller,et al.  A comprehensive, cell specific microRNA catalogue of human peripheral blood , 2017, Nucleic acids research.

[23]  J. Paul,et al.  MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients , 2017, World journal of gastroenterology.

[24]  C. Wijmenga,et al.  A large variety of clinical features and concomitant disorders in celiac disease - A cohort study in the Netherlands. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[25]  T. Vatanen,et al.  The influence of a short-term gluten-free diet on the human gut microbiome , 2016, Genome Medicine.

[26]  K. Kaukinen,et al.  Novel diagnostic techniques for celiac disease , 2016, Expert review of gastroenterology & hepatology.

[27]  I. Comino,et al.  Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing , 2015, Gut.

[28]  B. Jabri,et al.  IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction , 2015, Nature Reviews Immunology.

[29]  M. Mearin,et al.  Coeliac disease and gluten-related disorders in childhood , 2015, Nature Reviews Gastroenterology &Hepatology.

[30]  Jun Ye,et al.  Association Between Coeliac Disease and Risk of Any Malignancy and Gastrointestinal Malignancy , 2015, Medicine.

[31]  C. Wijmenga,et al.  Coeliac disease and autoimmune disease—genetic overlap and screening , 2015, Nature Reviews Gastroenterology &Hepatology.

[32]  D. Barisani,et al.  miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation , 2015, Genes & Nutrition.

[33]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[34]  J. Bai,et al.  Advances in diagnosis and management of celiac disease. , 2015, Gastroenterology.

[35]  S. Withoff,et al.  Small and Long Regulatory RNAs in the Immune System and Immune Diseases , 2014, Front. Immunol..

[36]  H. Putter,et al.  Randomized feeding intervention in infants at high risk for celiac disease. , 2014, The New England journal of medicine.

[37]  M. Muckenthaler,et al.  miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease , 2014, The American Journal of Gastroenterology.

[38]  D. Sanders,et al.  Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology , 2014, Gut.

[39]  F. Pérez-Bravo,et al.  MicroRNAs: an epigenetic tool to study celiac disease. , 2014, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[40]  M. Bardella,et al.  microRNA profiles in coeliac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts. , 2014, Clinical science.

[41]  R. Regazzi,et al.  Circulating microRNAs as novel biomarkers for diabetes mellitus , 2013, Nature Reviews Endocrinology.

[42]  F. Marabita,et al.  Identification of serum and tissue micro‐RNA expression profiles in different stages of inflammatory bowel disease , 2013, Clinical and experimental immunology.

[43]  Yongzhi Yang,et al.  MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury , 2013, PloS one.

[44]  Agnieszka Smolinska,et al.  Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet , 2013, Journal of breath research.

[45]  G. Eslick,et al.  Meta‐analysis: coeliac disease and the risk of all‐cause mortality, any malignancy and lymphoid malignancy , 2012, Alimentary pharmacology & therapeutics.

[46]  K. Giersiepen,et al.  European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[47]  L. Greco,et al.  MicroRNA-449a Overexpression, Reduced NOTCH1 Signals and Scarce Goblet Cells Characterize the Small Intestine of Celiac Patients , 2011, PloS one.

[48]  J. Abed,et al.  Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis , 2011, Gut.

[49]  G. Calin,et al.  MicroRNAs in body fluids—the mix of hormones and biomarkers , 2011, Nature Reviews Clinical Oncology.

[50]  M. Leonard,et al.  Circulating MicroRNA Is a Biomarker of Pediatric Crohn Disease , 2011, Journal of pediatric gastroenterology and nutrition.

[51]  H. Putter,et al.  The PreventCD Study design: towards new strategies for the prevention of coeliac disease , 2010, European journal of gastroenterology & hepatology.

[52]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[53]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[54]  F. Schmidt.  Meta-Analysis , 2008 .

[55]  N. Cerf-Bensussan,et al.  Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. , 2007, Gastroenterology.

[56]  Ren Da-hong.  The role of gene expression profile chip in the prediction of cervical intraepithelial neoplasia to cervical cancer , 2013 .